| Complicated Appendicitis in COVID-19 Era (NCT05012839) | National Taiwan University Hospital | 2017-01-01 |
| COVID-19 and Acute Invasive Fungal Rhinosinusitis (NCT04809480) | Al-Azhar University | 2017-01-01 |
| High Resolution Micro OCT Imaging (NCT03256773) | University of Alabama at Birmingham | 2016-04-15 |
| A Patient-Centered PaTH to Addressing Diabetes (NCT02788903) | Milton S. Hershey Medical Center | 2016-03-01 |
| Tobacco Use and the Risk of COVID-19 (NCT04896918) | Karolinska Institutet | 2015-10-01 |
| Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes (NCT02081326) | Massachusetts General Hospital | 2015-06-01 |
| Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls (NCT04974775) | Skane University Hospital | 2014-06-01 |
| Physical Activity and the Risk of COVID-19 Infection and Mortality (NCT04631861) | Wonju Severance Christian Hospital | 2014-01-01 |
| European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol (NCT04677842) | PENTA Foundation | 2013-01-01 |
| Sotrovimab Expanded Access Treatment Protocol (COVID-19) (NCT05235347) | Vir Biotechnology, Inc. | |
| Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS (NCT04657458) | Direct Biologics, LLC | |
| Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia (NCT04636554) | Adaptive Phage Therapeutics, Inc. | |
| Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19 (NCT04646031) | Tasly Pharmaceuticals, Inc. | |
| COVID-19 Soliris Expanded Access Protocol (NCT04802083) | Alexion Pharmaceuticals, Inc. | |
| Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19 (NCT04338360) | Mayo Clinic | |
| Expanded Access to Zofin for Patients With COVID-19 (NCT04657406) | ZEO ScientifiX, Inc. | |
| Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia (NCT04597242) | ContraFect | |